首页> 中文期刊> 《中医药学报》 >扶正解毒法干预宫颈 HR-HPV感染的临床研究

扶正解毒法干预宫颈 HR-HPV感染的临床研究

         

摘要

Objective: To study Fuzheng Jiedu therapy in the treatment of cervical high -risk human papilloma virus (HR-HPV) infection and changes of serum IL -6.Discuss the clinical value and action mechanism of Fuzheng Jiedu therapy in the treatment of cervical HR -HPV.Methods:According to the random method ,120 cases of cervical HR-HPV infection patients were divided into three groups : Chinese Medication combination group ( taking orally with Fuzheng Jiedu soup and external use of Xiaodu powder ) , Chinese medication external use group , western medication (interferon-alpha) external use group.Change of the symptom,the score of symptom,the viral loads of HR-HPV,the serum IL-6 were compared among three groups .Results: After treatment , the Chinese medication combination group had an obviously better effect than other two control groups ,the Chinese medication combination group ’ s viral loads of HR-HPV declined faster than those in other two control goups , and there was a significant difference among three groups ( P<0 .05 ) .Before treatment , the serum IL-6 value of the three groups had no significantly statistical difference (P>0.05).After treatment, the Chinese medication combination group’s serum IL-6 value decreased significantly, the serum IL-6 value of other two control groups had no obvious change ,and there was a significant difference among three groups ( P<0 .05 ) .Conclusion:Fuzheng Jiedu therapy has an obvious effect in the treatment of cervical high -risk human papilloma virus(HR-HPV),and can improve the immune function of organism and block the progress of the cervical virus.%目的:观察扶正解毒法干预宫颈高危型人乳头瘤病毒(简称HR-HPV)感染的临床疗效及患者体内血清IL-6的变化,探讨扶正解毒法干预宫颈HR-HPV感染的临床价值及作用机制。方法:将宫颈高危型人乳头状病毒感染患者120例随机分成中药联合组(口服扶正解毒汤联合外用清毒散),单纯中药上药组和西药上药组(α-干扰素),比较三组治疗前后症状、体征积分,HR-HPV病毒载量及血清IL-6的变化。结果:治疗后中药联合组分别与对照组中药上药组、西药上药组比较,症状、体征积分下降更明显,说明中药联合组能明显改善患者症状、体征评分,且优于对照组;治疗后中药联合组与对照组中药上药组、西药上药组比较,病毒载量下降更快,差异有统计学意义(P<0.05)。说明中药联合组能显著降低HPV载量值,且明显优于对照组中药上药组和西药上药组;三组治疗前血清IL-6差异无统计学意义(P>0.05),治疗后中药联合组血清IL-6下降明显,而中药上药组和西药上药组无明显变化,差异有统计学意义(P<0.05)。结论:中药扶正解毒法能有效治疗宫颈高危型人乳头状病毒感染,提高机体免疫功能,阻断宫颈疾病进展。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号